Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
4.5
-125.96%
40%
—
26x
80%
—
5 Years
Score4.5
Net Growth-125.96%
Net Trend40%
Net Income Consistency—
Rev Growth26x
Rev Trend80%
Revenue Consistency—
XTL Biopharmaceuticals Ltd ADR fundamental performance
Between 2019 and 2024, revenue grew from $ 69K to $ 451K and net income went from -$ 1M to -$ 1M. Revenue increased in 4 of those 5 years; net income in 2.
Between 2014 and 2024, revenue grew from $ 41K to $ 451K and net income went from -$ 2M to -$ 1M. Revenue increased in 8 of those 10 years; net income in 6.
XTL Biopharmaceuticals Ltd ADR currently holds a 20-year HDB Score of 2.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 2.69 | — |
1 Year2025-08-12 | $ 5.54 | -51.45% |
5 Years2021-08-12 | $ 15.20 | -82.30% |
10 Years2016-08-12 | $ 22.30 | -87.94% |
20 Years2006-08-11 | $ 640.00 | -99.58% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | 20 Years2006-08-11 |
|---|---|---|---|---|---|
| Price | $ 2.69 | $ 5.54 | $ 15.20 | $ 22.30 | $ 640.00 |
| Return | — | -51.45% | -82.30% | -87.94% | -99.58% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2025 | $ 740K | -$ 1M | $ 1M |
| 2024 | $ 451K | -$ 1M | $ 1M |
| 2023 | $ 0.00 | -$ 1.78K | $ 2M |
| 2022 | -$ 459K | -$ 1M | $ 3M |
| 2021 | $ 1M | $ 435K | $ 6M |
| 2020 | $ 28K | -$ 782K | $ 6M |
| 2019 | $ 69K | -$ 1M | $ 6M |
| 2018 | $ 52K | $ 2M | $ 8M |
| 2017 | $ 29K | -$ 781K | $ 6M |
| 2016 | $ 23K | -$ 2M | $ 2M |
| 2015 | -$ 6K | -$ 4M | $ 4M |
| 2014 | $ 41K | -$ 2M | $ 2M |
| 2013 | $ 2M | -$ 2M | $ 4M |
| 2012 | $ 938K | -$ 1M | $ 3M |
| 2011 | -$ 1M | $ 1M | |
| 2010 | -$ 1M | $ 1M | |
| 2009 | $ 2M | $ 412K | |
| 2008 | $ 5M | -$ 9M | $ 2M |
| 2007 | $ 907K | -$ 24M | $ 12M |
| 2006 | $ 454K | -$ 15M | $ 25M |
| IPO2005 | $ 3M | -$ 14M | $ 13M |
Explore beyond XTLB
You're looking at XTL Biopharmaceuticals Ltd ADR. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
